Adial Pharmaceuticals
Price & Volume
Stats
See more52W Range | $1.54-$21.37 |
Market Cap | $2.2M |
Shares Short | 79,609 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$11.93 |
News
See moreYahoo Finance • last month
Adial Pharmaceuticals Reports 2025 Fiscal Year Financial Results and Provides Business Update
Yahoo Finance • 2 months ago
Adial Applauds Congressional Directive Advancing Alternative Clinical Trial Endpoints for Substance Use Disorders, Strengthening Regulatory Path for AD04
Yahoo Finance • 2 months ago
Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement
Yahoo Finance • 5 months ago
Adial Pharmaceuticals Announces a Warrant Inducement Transaction for Approximately $2.86 Million in Gross Proceeds
About
CEO | Mr. Cary John Claiborne MBA |
CFO | Mr. Vinay Shah A.C.A., C.P.A., M.B.A. |
Address | 4870 Sadler Road, Glen Allen, VA, United States, 23060 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 5 |
